April 28, 2023
The paper summarizes the rationale for using proprietary blends in dietary supplements, how they are regulated and labeled, as well as the challenges this presents for researchers.
April 25, 2023
Industry advocates defend the safety record of melatonin and criticize the letter as misleading and ill-informed.
The review raises concerns about the potential toxicity of CBD but industry advocates contend that the research is misleading and outside of the scope of dietary supplement products.
Steve Mister, president and CEO of CRN sits down with Nutritional Outlook at SupplySide East to discuss the recent Ipsos survey the group commissioned with CHPA, as well as other regulatory updates.
April 20, 2023
After the Supreme Court ruled that FTC can no longer collect consumer redress in court, FTC has revived, with vigor, a decades-long enforcement tool: Notice of Penalty Offenses.
Two identical bills have been introduced to the New York State Assembly (A05610-B) and Senate (S05823B) are an updated version of previous bills (S-16/A431) vetoed by Governor Kathy Hochul in January of 2023.
April 19, 2023
CITES is an international agreement between governments to ensure that international trade involving wild animals and plants is conducted in a way that does not threaten the survival of animal and plant species.
April 17, 2023
HP Ingredients has announced an independent conclusion of GRAS (generally recognized as safe) for its Bergamonte bergamot extract.
According to Nutrasource, this is the first time that a supplement manufactured in South Korea will bear the IFOS label without having to import ingredients or be manufactured outside the country.
April 14, 2023
NOW is asking Amazon to recall the products, which fraudulently claim to be from NOW itself as well as from another unnamed leading supplement brand.